Genomic Test Says It Can Help Determine How Breast Cancer Will Progress
Thursday, February 12, 2009 - 23:56
in Health & Medicine
Scientists at the University of North Carolina at Chapel Hill say they have helped develop a new genomic test that can help clinicians predict which breast cancer patients are most likely to survive the disease and which treatments may be most effective in increasing those chances of survival. By specifically measuring the activity level of a small subset of the 20,000 plus genes that may be “turned on” or “turned off” within each tumor, this genomic test can give patients a more accurate picture of how their disease might progress. read more
Read the whole article on Scientific Blogging
More from Scientific Blogging
Related
- New genomic test can personalize breast cancer treatmentMon, 9 Feb 2009, 16:37:15 EST
- Genetic changes shown to be important indicators for disease progression in cervical cancer patientsFri, 13 Nov 2009, 7:25:31 EST
- Genetic changes shown to be important indicators for disease progression in cervical cancer patientsFri, 13 Nov 2009, 7:25:28 EST
- Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancerTue, 3 Feb 2009, 10:43:42 EST
- Specific gene increases susceptibility to breast cancerMon, 5 May 2008, 20:21:20 EDT